4.7 Article

Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models

期刊

SCIENTIFIC REPORTS
卷 11, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-021-96181-2

关键词

-

资金

  1. Australian National Health and Medical Research Council [1006141, 1030513, 1086887]
  2. Dementia Teams Research Grant [1095215]
  3. Fight MND Foundation
  4. Motor Neuron Disease Research Institute of Australia
  5. National Health and Medical Research Council of Australia [1086887] Funding Source: NHMRC

向作者/读者索取更多资源

Mutations in the Fused in Sarcoma (FUS) gene result in mislocalization of the FUS protein from the nucleus to the cytoplasm, leading to inclusion formation, defects in nucleocytoplasmic transport, Golgi fragmentation, and ER stress. Protein disulfide isomerase (PDI) has been shown to have a protective role against FUS-associated ALS, restoring defects in nuclear import, preventing inclusion formation, Golgi fragmentation, ER stress, ER-Golgi transport defects, and apoptosis in neuronal cells.
Mutations in Fused in Sarcoma (FUS) are present in familial and sporadic cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). FUS is localised in the nucleus where it has important functions in DNA repair. However, in ALS/FTD, mutant FUS mislocalises from the nucleus to the cytoplasm where it forms inclusions, a key pathological hallmark of neurodegeneration. Mutant FUS also inhibits protein import into the nucleus, resulting in defects in nucleocytoplasmic transport. Fragmentation of the neuronal Golgi apparatus, induction of endoplasmic reticulum (ER) stress, and inhibition of ER-Golgi trafficking are also associated with mutant FUS misfolding in ALS. Protein disulphide isomerase (PDI) is an ER chaperone previously shown to be protective against misfolding associated with mutant superoxide dismutase 1 (SOD1) and TAR DNA-binding protein-43 (TDP-43) in cellular and zebrafish models. However, a protective role against mutant FUS in ALS has not been previously described. In this study, we demonstrate that PDI is protective against mutant FUS. In neuronal cell line and primary cultures, PDI restores defects in nuclear import, prevents the formation of mutant FUS inclusions, inhibits Golgi fragmentation, ER stress, ER-Golgi transport defects, and apoptosis. These findings imply that PDI is a new therapeutic target in FUS-associated ALS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据